{
    "code": "02021919",
    "time": "2015-08-21 06:41:45",
    "許可證字號": "衛署藥輸字第021919號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/06\/29",
    "註銷理由": "自請註銷",
    "有效日期": "107\/02\/28",
    "發證日期": "86\/10\/15",
    "許可證種類": "製　劑",
    "舊證字號": "02015697",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202191902",
    "中文品名": "溶栓酉每凍晶注射劑７５０，０００單位",
    "英文品名": "STREPTASE 750,000I.U. LYOPHILIZED FOR INJECTION",
    "適應症": "血栓及栓塞之纖維溶解劑。",
    "劑型": "243凍晶注射劑",
    "包裝": "100小瓶盒裝 750000單位小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "STREPTOKINASE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0601501100  吉發企業股份有限公司",
    "申請商地址": "台北市愛國西路９號２Ｆ之９",
    "主製造廠": {
        "製造廠名稱": "F470241000  CSL BEHRING GMBH",
        "製造廠廠址": "EMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANY",
        "製造廠公司地址": "EMIL-VON-BEHRING-STRASSE 76,35041, MARBURG,GERMANY (P.O. BOX)1230,D-35002 MARBURG, GERMANY",
        "製造廠國別": "GERMANY",
        "製程": ""
    },
    "CCC號列": "30021090001 其他血液分離部分及改質免疫產品，不論是否以生物技術方法取得Other blood fractions and modified immunological products, whether or not obtained by means of biotechnological process",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2040000100",
            "成分名稱": "STREPTOKINASE",
            "含量描述": "",
            "含量": "750000.0000000000",
            "單位": "I.U."
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020219190005___20130116.pdf 020219190004___20130116.pdf 020219190003.jpg 020219190002.jpg 020219190001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021919&Seq=005&Type=9"
        },
        {
            "title": "外盒 020219190003___20130116.pdf 020219190002___20130116.pdf 020219190001___20130116.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021919&Seq=003&Type=8"
        }
    ]
}